Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14:576–590. https://doi.org/10.1038/s41574-018-0059-4

Article  CAS  PubMed  Google Scholar 

Yousefzadeh MJ, Zhao J, Bukata C, Wade EA, McGowan SJ, Angelini LA, Bank MP, Gurkar AU, McGuckian CA, Calubag MF, Kato JI, Burd CE, Robbins PD, Niedernhofer LJ (2020) Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell 19:e13094. https://doi.org/10.1111/acel.13094

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campisi J, Robert L (2014) Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol 39:45–61. https://doi.org/10.1159/000358899

Article  PubMed  PubMed Central  Google Scholar 

Liu T, Zhang L, Joo D, Sun SC (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2:17023. https://doi.org/10.1038/sigtrans.2017.23

Article  PubMed  PubMed Central  Google Scholar 

Chan C, Li L, McCall CE, Yoza BK (2005) Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J Immunol 175:461–468. https://doi.org/10.4049/jimmunol.175.1.461

Article  CAS  PubMed  Google Scholar 

Salminen A, Paimela T, Suuronen T, Kaarniranta K (2008) Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90. Immunol Lett 117:9–15. https://doi.org/10.1016/j.imlet.2007.12.017

Article  CAS  PubMed  Google Scholar 

van Eden W, Jansen MAA, Ludwig I, van Kooten P, van der Zee R, Broere F (2017) The enigma of heat shock proteins in immune tolerance. Front Immunol 8:1599. https://doi.org/10.3389/fimmu.2017.01599

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ (2013) The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 138:105–115. https://doi.org/10.1111/imm.12036

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amodio G, Cichy J, Conde P, Matteoli G, Moreau A, Ochando J, Oral BH, Pekarova M, Ryan EJ, Roth J et al (2019) Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation. Cancer Immunol Immunother 68:661–672. https://doi.org/10.1007/s00262-018-2264-3

Article  PubMed  Google Scholar 

Salminen A (2020) Activation of immunosuppressive network in the aging process. Ageing Res Rev 57:100998. https://doi.org/10.1016/j.arr.2019.100998

Article  CAS  PubMed  Google Scholar 

Lian J, Yue Y, Yu W, Zhang Y (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol 13:151. https://doi.org/10.1186/s13045-020-00986-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monneret G, Gossez M, Venet F (2021) Sepsis and immunosenescence: closely associated in a vicious circle. Aging Clin Exp Res 33:729–732. https://doi.org/10.1007/s40520-019-01350-z

Article  PubMed  Google Scholar 

Salminen A (2021) Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions. J Mol Med (Berl) 99:1553–1569. https://doi.org/10.1007/s00109-021-02123-w

Article  CAS  PubMed  Google Scholar 

Ghosh C, Luong G, Sun Y (2021) A snapshot of the PD-1/PD-L1 pathway. J Cancer 12:2735–2746. https://doi.org/10.7150/jca.57334

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki IM, Okazaki T (2019) PD-1 primarily targets TCR signal in the inhibition of functional T cell activation. Front Immunol 10:630. https://doi.org/10.3389/fimmu.2019.00630

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pawelec G, Remarque E, Barnett Y, Solana R (1998) T cells and aging. Front Biosci 3:d59–d99. https://doi.org/10.2741/a266

Article  CAS  PubMed  Google Scholar 

Rodriguez IJ, Lalinde Ruiz N, Llano Leon M, Martinez Enriquez L, Montilla Velasquez MDP, Ortiz Aguirre JP, Rodriguez Bohorquez OM, Velandia Vargas EA, Hernandez ED, Parra Lopez CA (2021) Immunosenescence study of T cells: a systematic review. Front Immunol 11:604591. https://doi.org/10.3389/fimmu.2020.604591

Article  CAS  PubMed  PubMed Central  Google Scholar 

Onorati A, Havas AP, Lin B, Rajagopal J, Sen P, Adams PD, Dou Z (2022) Upregulation of PD-L1 in senescence and aging. Mol Cell Biol 42:e0017122. https://doi.org/10.1128/mcb.00171-22

Article  CAS  PubMed  Google Scholar 

Pippin JW, Kaverina N, Wang Y, Eng DG, Zeng Y, Tran U, Loretz CJ, Chang A, Akilesh S, Poudel C et al (2022) Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease. J Clin Invest 132:e156250. https://doi.org/10.1172/JCI156250

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang TW, Johmura Y, Suzuki N, Omori S, Migita T, Yamaguchi K, Hatakeyama S, Yamazaki S, Shimizu E, Imoto S et al (2022) Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes. Nature 611:358–364. https://doi.org/10.1038/s41586-022-05388-4

Article  CAS  PubMed  Google Scholar 

Beenen AC, Sauerer T, Schaft N, Dörrie J (2022) Beyond cancer: regulation and function of PD-L1 in health and immune-related diseases. Int J Mol Sci 23:8599. https://doi.org/10.3390/ijms23158599

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Qu Y, Hao C, Yao W (2023) PD-1/PD-L1 axis in organ fibrosis. Front Immunol 14:1145682. https://doi.org/10.3389/fimmu.2023.1145682

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027–1034. https://doi.org/10.1084/jem.192.7.1027

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariotti FR, Quatrini L, Munari E, Vacca P, Moretta L (2019) Innate lymphoid cells: expression of PD-1 and other checkpoints in normal and pathological conditions. Front Immunol 10:910. https://doi.org/10.3389/fimmu.2019.00910

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quatrini L, Mariotti FR, Munari E, Tumino N, Vacca P, Moretta L (2020) The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy. Cancers (Basel) 12:3285. https://doi.org/10.3390/cancers12113285

Article  CAS  PubMed  Google Scholar 

Stanford SM, Rapini N, Bottini N (2012) Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity. Immunology 137:1–19. https://doi.org/10.1111/j.1365-2567.2012.03591.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baldanzi G (2022) Immune checkpoint receptors signaling in T cells. Int J Mol Sci 23:3529. https://doi.org/10.3390/ijms23073529

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Bardhan K, Boussiotis VA, Patsoukis N (2021) The PD-1 interactome. Adv Biol (Weinh) 5:e2100758. https://doi.org/10.1002/adbi.202100758

Article  CAS  PubMed  Google Scholar 

Hou B, Hu Y, Zhu Y, Wang X, Li W, Tang J, Jia X, Wang J, Cong Y, Quan M et al (2024) SHP-1 regulates CD8+ T cell effector function but plays a subtle role with SHP-2 in T cell exhaustion due to a stage-specific nonredundant functional relay. J Immunol 212:397–409. https://doi.org/10.4049/jimmunol.2300462

Article  CAS  PubMed  Google Scholar 

Niu C, Li M, Zhu S, Chen Y, Zhou L, Xu D, Xu J, Li Z, Li W, Cui J (2020) PD-1-positive natural killer cells have a weaker antitumor function than that of PD-1-negative natural killer cells in lung cancer. Int J Med Sci 17:1964–1973. https://doi.org/10.7150/ijms.47701

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thibult ML, Mamessier E, Gertner-Dardenne J, Pastor S, Just-Landi S, Xerri L, Chetaille B, Olive D (2013) PD-1 is a novel regulator of human B-cell activation. Int Immunol 25:129–137. https://doi.org/10.1093/intimm/dxs098

Article  CAS  PubMed